Spinal cord stimulation reduces phantom limb pain by 70% in amputees

Among the 1.5 million Americans living with a lower-limb amputation, roughly eight in ten wake each day with a persistent problem: pain emanating from a limb that no longer exists. Phantom limb pain, as it's called, resists most medications and erodes quality of life in ways that extend far beyond the physical sensation itself. Amputees also struggle with balance and falls because even the most advanced prosthetics lack any sensory connection to the body—they are, in effect, blind extensions. A research team at the University of Pittsburgh has now demonstrated that a relatively straightforward intervention can address both problems at once.

The approach uses technology already familiar to pain specialists: spinal cord stimulation devices, which physicians have been implanting for years. What makes this application novel is how the researchers deployed it. They embedded pressure sensors into the insole of a prosthetic foot. When an amputee stands or walks, those sensors detect the weight and pressure distribution beneath the artificial limb. That information is then converted into electrical pulses and delivered to electrodes positioned over the spinal cord in the lower back. The result is a restoration of sensory feedback—the body receives signals that mimic what the missing foot would normally report.

In their proof-of-concept trial, participants received thin electrode strands implanted over the spinal cord, connected to a cell phone-sized stimulation device. The leads remained in place for one to three months, allowing researchers to test the system under various conditions. What they found was striking: participants reported an average 70 percent reduction in phantom limb pain. Beyond pain relief, the sensory feedback produced measurable improvements in balance and gait stability, even in challenging scenarios like standing on a moving platform with eyes closed. For people whose mobility has been constrained by both pain and instability, this represents a meaningful shift.

Lee Fisher, the study's senior author and an associate professor of physical medicine and rehabilitation at Pittsburgh, emphasized that the team was not inventing new hardware. "We are using electrodes and stimulation devices that are already frequently used in the clinic and that physicians know how to implant," he said. The innovation lay in repurposing existing technology to restore sensory connections rather than simply blocking pain signals—a distinction that matters. Traditional spinal cord stimulation works by overwhelming pain neurons with competing sensory input, much like rubbing a bruised elbow. Fisher's group instead used the same stimulation mechanism to replace the severed neural pathways between the missing foot and the central nervous system.

The research team, which included pain medicine physicians Eric Helm and Vincent Miele, was able to adjust stimulation parameters in real time as subjects moved. This active control—the ability to modulate the intensity and frequency of electrical pulses based on actual pressure on the prosthetic foot—distinguishes the work from previous attempts by other research groups. The versatility of the approach also matters for practical implementation. The system functioned in people with amputations caused by trauma as well as in those with extensive nerve damage from chronic conditions like diabetes. It required no custom-made electrodes or uncommon surgical procedures, which means it could potentially be scaled across the country without prohibitive technical or financial barriers.

Fisher noted that the method works as long as the spinal cord itself remains intact—a condition met in the vast majority of lower-limb amputees. With proper support from industry partners, he suggested, clinical translation could happen within five years. For 1.5 million Americans currently managing phantom limb pain with limited options, that timeline carries real weight. The study was supported by the National Institutes of Health and the Swiss National Science Foundation, and included collaborators from Carnegie Mellon University and the University of Chicago. What began as a proof of concept may soon become a standard offering in pain clinics across the country.